MeiraGTx Holdings plc Other Long-term Investments
MeiraGTx Holdings plc (MGTX) had Other Long-term Investments of $1.50 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Assets
us-gaap:OtherLongTermInvestments · last filed 2022-11-10
- 2022-09-30: Other Long-term Investments $1.50M.
- 2022-06-30: Other Long-term Investments $1.50M.
- 2022-03-31: Other Long-term Investments $1.50M.
- 2021-12-31: Other Long-term Investments $1.50M.
| Period end | Other Long-term Investments |
|---|---|
| 2022-09-30 | $1.50M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.50M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.50M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.50M 10-K · filed 2022-03-10 |
| 2021-09-30 | $1.50M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.50M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $1.50M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |